Use App
Trending
News
Earnings
Newsletters
Work With Us
All
DIA
0.25%
SPY
0.50%
QQQ
1.12%
Trending
LUNR
16.51%
CRCL
20.78%
NVTS
15.56%
ODD
51.76%
LITE
7.93%
CAVA
21.75%
LCID
2.27%
NVDA
1.52%
ZETA
3.36%
WDAY
0.25%
LUNR
16.51%
CRCL
20.78%
NVTS
15.56%
ODD
51.76%
LITE
7.93%
CAVA
21.75%
LCID
2.27%
NVDA
1.52%
ZETA
3.36%
WDAY
0.25%
home
Symbol
NVOX
NVOX
Defiance Daily Target 2X Long NVO ETF
183
Volume
1.11M
52W High
$100.40
52W Low
$10.83
50D MA
$23.37
Prev Close
$10.92
Loading...
Loading...
Feed
News
Sentiment
Fundamentals
Info
News
all
press releases
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
The request applies to GLP-1 RAs approved for obesity, including Novo Nordisk’s Wegovy and Saxenda and Eli Lilly’s Zepbound.
Stocktwits
·
1mo ago
Full Article
<
...
1
>
Latest NVOX News
View
Top Discussions
top
active
trending
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile